http://www.fpnotebook.com/
ProcainamideAka: Pronestyl
- Mechanism
- Suppresses ventricular ectopy
- Suppresses Phase 4 diastolic depolarization
- Reduces automaticity of all Pacemakers
- Slows intraventricular conduction
- May terminate reentrant arrhythmias
- Indications
- Ventricular Tachycardia (refractory to Lidocaine)
- Ventricular Fibrillation
- Atrial Fibrillation Rate Control and cardioversion
- Time to Cardioversion: 1 hour
- Conversion Rate: 20%
- Chronic Efficacy: 50%
- Relative Contraindications
- Acute Myocardial Infarction
- Hypokalemia
- Hypomagnesemia
- Preparation
- Blood Pressure monitoring
- Electrocardiogram Monitoring
- Endpoints to Dosing
- Arrhythmia is suppressed
- Hypotension
- QRS Complex widening over 50% of original width
- PR interval or QT Interval lengthening over 50%
- Max total dose reached: 17 mg/kg administered
- Dose: Child
- Load: 15 mg/kg in D5W IV over 30 minutes
- Maintenance: 20 to 80 ug/kg/minute
- Dose: Adult
- Load: 20-30 mg/min until any above endpoint reached
- Max Total Dose: 17 mg/kg
- Maintenance: 1-4 mg/min
- Start after effect is achieved with loading dose
- Adverse Effects
- Hypotension
- Electrocardiogram changes
- QRS Complex widening
- PR interval lengthening
- QT Interval lengthening
- Atrioventricular conduction disturbance
- AV Block
- Cardiac arrest
- Malignant Ventricular arrhythmia
Navigation Tree